Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
This study has been completed.
Study NCT00177671 Information provided by University of Pittsburgh
First Received on September 13, 2005. Last Updated on January 31, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Dementia
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Mood Disorders
Nervous System Diseases
Interventions listed in this trial
Escitalopram
Donepezil
Venlafaxine
Placebo
Duloxetine
Additional drug interventions recognized in this trial
Antidepressive Agents
Citalopram
Dexetimide
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Anti-Dyskinesia Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Cholinesterase Inhibitors
Dopamine Agents
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Nootropic Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Pittsburgh
National Institute of Mental Health (NIMH)
Back to top of Main Content
